XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
  Cornea
  Cataract
  Retina
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Ophthalmology Channel
subscribe to Ophthalmology newsletter

Latest Research : Ophthalmology

   DISCUSS   |   EMAIL   |   PRINT
Infant vernier acuity is not as immature as previous research has indicated
Mar 23, 2005, 23:16, Reviewed by: Dr.

"The data from this study also suggest that vernier testing could be a substitute for eye chart testing for children and others who cannot read an eye chart"

 
Infant vernier acuity is not as immature as previous research has indicated.

The data from this study also suggest that vernier testing could be a substitute for the traditional Snellen eye chart test for children or others who cannot read letters. Vernier acuity is tested by viewing nearly collinear stripes with varying amounts of spatial phase displacement between them and measuring an individual's ability to gauge the displacement between the stripes.

Angela M. Brown, Veena Adusumilli, and Delwin T. Lindsey of The Ohio State University conducted the study with major funding from the National Eye Institute and the National Science Foundation. The researchers first set out to establish a "benchmark" to which vernier acuity could be compared. The benchmark they chose was the ability to see small differences in contrast. Adults (ages 20 to 48) were tested 6.096 meters (20 feet) from the contrast stimuli, and healthy three-month-old infants were tested 45.72 centimeters (1.5 feet) from the contrast stimuli, to take into account the underdeveloped vision of infants. The experiment showed that under these conditions, infants see changes contrast almost as well as adults.

The vernier acuity of the infants and adults was then tested under the same conditions as the contrast discrimination had been tested. Under these conditions, infant vernier acuity (in degrees of spatial phase displacement) was almost as good as that of adults. Furthermore, the relation between "benchmark" contrast discrimination ability and vernier acuity was the same for infants and adults.

During the testing, an adult observer held an infant in her arms using a "baby sling," standing in a position that allowed the infant to see the stimulus display, but the adult observer could not. The adult observer watched the infant's looking behavior via closed-circuit video and judged whether the test stimulus (the modulation of stimulus displacement or contrast) was contained in the right- or left-side stripes. This is an objective measure of how well infants can see a stimulus, and is in common use in the laboratory and the clinic.

Angela Brown, lead researcher of the study, says the data suggest that vernier acuity of human infants and adults is quite similar, contrary to past studies conducted in this area. The similarity of infant and adult vernier acuity suggests that vernier acuity might be a sensitive test for strabismic amblyopia and other visual disorders that normally must be diagnosed using an eye chart. "The data from this study also suggest that vernier testing could be a substitute for eye chart testing for children and others who cannot read an eye chart," says Brown.
 

- Study published in March in the Journal of Vision, an online, free access publication of the Association for Research in Vision and Ophthalmology (ARVO)
 

You can read this article online in Journal of Vision

 
Subscribe to Ophthalmology Newsletter
E-mail Address:

 

The Association for Research in Vision and Ophthalmology, Inc. (ARVO) is a 77-year-old membership organization of more than 11,200 eye and vision researchers from over 70 countries. The Association encourages and assists its members and others in research, training, publication and dissemination of knowledge in vision and ophthalmology. ARVO's headquarters are located in Rockville, Maryland. The Association's Web site is www.arvo.org.

Journal of Vision is published by ARVO, the Association for Research in Vision and Ophthalmology. All articles are free and open to anyone.


Related Ophthalmology News

Master Proteins Dictate Retinal Differentiation Timetable
Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Objective way to diagnose diseases of colour perception
Onchocerciasis treatment reduces prevalence and intensity by 38%
Antioxidants may slow retinal degeneration
Hormone Therapy Does Not Affect Age-Related Vision Loss
Eating Fish Protects Against Macular Degeneration
Research Highlights Risk Factors For Age-Related Vision Loss
How Thalamic Neurons Grab Your Attention
FDA approves ranibizumab for the treatment of wet age-related macular degeneration


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us